Zeng Lingyi, Zhang Jisheng, Li Chunjiang, Fu Yanjun, Zhao Yongxin, Wang Yong, Zhao Jing, Guo Yuhang, Zhang Xiaoli
Department of Microbiology, The First Affiliated Hospital of Jiamusi University, Jiamusi 154002, China.
Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402106, China.
Infect Genet Evol. 2020 Aug;82:104319. doi: 10.1016/j.meegid.2020.104319. Epub 2020 Apr 8.
There is increasing resistance to carbapenems among Klebsiella pneumoniae,and fluoroquinolones (FQ) are increasingly used to treat infections from extended-spectrum β- lactamase(ESBLs) and carbapenemase-producing Klebsiella pneumoniae. However, the acquisition of plasmid-mediated quinolone resistance (PMQR) or the spontaneous mutation of the quinolone resistance-determining regions (QRDR) of the gyrA and parC genes can severely affect the therapeutic effect of quinolones. The goal of this study was to investigate the molecular determinants of FQ resistance(FQ-R) in carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from Heilongjiang Province,China.
We isolated 40 strains of CRKP from a treatment center in the eastern part of Heilongjiang Province from January 2016 to December 2018. The VITEK2 Compact analyzer was used to identify and detect drug sensitivity. Different types of drug resistance genes were detected by polymerase chain reaction (PCR). PCR and DNA sequencing were used to assess the presence of qnrA, qnrB, qnrS,qepA and acc(6') Ib-cr genes,which are plasmid-encode genes that can contribute to resistance. The sequences of gyrA and parC genes were sequenced and compared with the sequences of standard strains to determine if mutations were present.Multi-site sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) were performed on the strains to assess homology.
The isolated CRKP strains showed rates of resistance to fluoroquinolones of 22.5% to 42.5%. The resistance rate of ciprofloxacin was significantly higher than that of levofloxacin.Nine CRKP strains (22.5%) showed co-resistance to ciprofloxacin and levofloxacin.The quinolone resistant strains were screened for plasmid-encoded genes that can contribute to resistance (PMQR genes).Among the 17 quinolone resistant strains,one strain contained no PMQR genes,twelve strains contained two PMQR genes,and four strains contained four PMQR genes.Acc (6') Ib-cr was the most frequently detected PMQR gene, detected in 95% of strains tested (38 of 40) and in 94.1% of the quinolone-resistant strains (16 of 17). The qepA gene encoding an efflux pump was not detected in any strains.No isolate carried five different PMQRs simultaneously.Changes of S83I and D87G changes in gyrA, and the S80I change in parC,which were mediated by QRDR,were identified in two isolates,which showed resistance to both ciprofloxacin and levofloxacin.Most of the FQ-R strains(58.8%,10/17) belong to ST(sequence type) 76, which is dominant in the local area, while all the mutant strains (100%,2/2),that differ in at least one site from standard bacteria, belong to the ST11 group. The strains were isolated from a hospital where there had been a recent outbreak of ST76 type CRKP in the neurosurgery ward and intensive care unit.
CRKP strains were identified that were insensitive or even resistant to quinolones,and this resistance is common in Heilongjiang Province of eastern China;fluoroquinolone-resistance in these clinical CRKP strains is a complex interplay between PMQR determinants and mutations in gyrA and parC.The resistance level caused by QRDR mutation is higher than that caused by PMQR, however, the high frequency of PMQR genes in the isolated CRKP strains suggests the potential for impact of these genes.PMQR determinants are often found in carbapenemase-producing or ESBLs-producing Klebsiella pneumoniae,and some resistance genes,such as:SHV,TEM, CTX-M-15,and OXA-1 are closely associated with FQ-R. Finally, geographical factors can affect the emergence and spread of PMQR and QRDR.Some genetic lineages have higher potential risks, and continuous close monitoring is required.
肺炎克雷伯菌对碳青霉烯类药物的耐药性不断增加,氟喹诺酮类药物(FQ)越来越多地用于治疗产超广谱β-内酰胺酶(ESBLs)和碳青霉烯酶的肺炎克雷伯菌感染。然而,质粒介导的喹诺酮耐药性(PMQR)的获得或gyrA和parC基因喹诺酮耐药决定区(QRDR)的自发突变会严重影响喹诺酮类药物的治疗效果。本研究的目的是调查中国黑龙江省耐碳青霉烯类肺炎克雷伯菌(CRKP)分离株中FQ耐药性(FQ-R)的分子决定因素。
2016年1月至2018年12月,我们从黑龙江省东部的一个治疗中心分离出40株CRKP。使用VITEK2 Compact分析仪进行鉴定和药物敏感性检测。通过聚合酶链反应(PCR)检测不同类型的耐药基因。采用PCR和DNA测序评估qnrA、qnrB、qnrS、qepA和acc(6')Ib-cr基因的存在情况,这些基因是可导致耐药性的质粒编码基因。对gyrA和parC基因的序列进行测序,并与标准菌株的序列进行比较,以确定是否存在突变。对菌株进行多位点序列分型(MLST)和脉冲场凝胶电泳(PFGE)以评估同源性。
分离出的CRKP菌株对氟喹诺酮类药物的耐药率为22.5%至42.5%。环丙沙星的耐药率显著高于左氧氟沙星。9株CRKP菌株(22.5%)对环丙沙星和左氧氟沙星表现出共同耐药性。对喹诺酮耐药菌株进行可导致耐药性的质粒编码基因(PMQR基因)筛选。在17株喹诺酮耐药菌株中,1株不含PMQR基因,12株含有2个PMQR基因,4株含有4个PMQR基因。Acc(6')Ib-cr是最常检测到的PMQR基因,在95%的检测菌株(40株中的38株)和94.1%的喹诺酮耐药菌株(17株中的16株)中被检测到。在任何菌株中均未检测到编码外排泵的qepA基因。没有分离株同时携带5种不同的PMQRs。在2株对环丙沙星和左氧氟沙星均耐药的分离株中鉴定出由QRDR介导的gyrA中S83I和D87G变化以及parC中S80I变化。大多数FQ-R菌株(58.8%,10/17)属于ST(序列类型)76,这在当地占主导地位,而所有与标准细菌至少在一个位点不同的突变菌株(100%,2/2)属于ST11组。这些菌株是从一家医院分离出来的,该医院神经外科病房和重症监护病房最近爆发了ST76型CRKP。
鉴定出对喹诺酮类药物不敏感甚至耐药的CRKP菌株,这种耐药性在中国东部黑龙江省很常见;这些临床CRKP菌株中的氟喹诺酮耐药性是PMQR决定因素与gyrA和parC突变之间复杂的相互作用。由QRDR突变引起的耐药水平高于由PMQR引起的耐药水平,然而,分离出的CRKP菌株中PMQR基因的高频率表明这些基因可能产生影响。PMQR决定因素通常在产碳青霉烯酶或产ESBLs的肺炎克雷伯菌中发现,一些耐药基因,如:SHV、TEM、CTX-M-15和OXA-1与FQ-R密切相关。最后,地理因素可影响PMQR和QRDR的出现和传播。一些遗传谱系具有较高的潜在风险,需要持续密切监测。